0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Coagulation Factors - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-0B12513
Home | Market Reports | Health| Pharmacy
Global Coagulation Factors Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Coagulation Factors - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-0B12513
Report
September 2024
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Coagulation Factors - Market Size

The global market for Coagulation Factors was estimated to be worth US$ 12770 million in 2023 and is forecast to a readjusted size of US$ 18800 million by 2030 with a CAGR of 5.8% during the forecast period 2024-2030

Coagulation Factors - Market

Coagulation Factors - Market

Coagulation factors such as factor V, factor VIII and factor X play a role in blood clotting
The coagulation factors market has experienced substantial growth in recent years. Coagulation factors are essential proteins involved in the blood clotting process, and deficiencies or abnormalities in these factors can lead to bleeding disorders such as hemophilia and von Willebrand disease. The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Coagulation Factors, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Coagulation Factors by region & country, by Type, and by Application.
The Coagulation Factors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coagulation Factors.
Market Segmentation

Scope of Coagulation Factors - Market Report

Report Metric Details
Report Name Coagulation Factors - Market
Forecasted market size in 2030 US$ 18800 million
CAGR 5.8%
Forecasted years 2024 - 2030
Segment by Type:
  • Plasma-derived
  • Recombinant
Segment by Application
  • Pharmacy
  • Hospital
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk, Greencross, Kedrion, BPL, Hualan Bio, RAAS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Coagulation Factors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Coagulation Factors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Coagulation Factors in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Coagulation Factors - Market size in 2030?

Ans: The Coagulation Factors - Market size in 2030 will be US$ 18800 million.

Who are the main players in the Coagulation Factors - Market report?

Ans: The main players in the Coagulation Factors - Market are Takeda, Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk, Greencross, Kedrion, BPL, Hualan Bio, RAAS

What are the Application segmentation covered in the Coagulation Factors - Market report?

Ans: The Applications covered in the Coagulation Factors - Market report are Pharmacy, Hospital

What are the Type segmentation covered in the Coagulation Factors - Market report?

Ans: The Types covered in the Coagulation Factors - Market report are Plasma-derived, Recombinant

Recommended Reports

Coagulation Diagnostics

Hemophilia & Bleeding

Coagulation Reagents

1 Market Overview
1.1 Coagulation Factors Product Introduction
1.2 Global Coagulation Factors Market Size Forecast
1.2.1 Global Coagulation Factors Sales Value (2019-2030)
1.2.2 Global Coagulation Factors Sales Volume (2019-2030)
1.2.3 Global Coagulation Factors Sales Price (2019-2030)
1.3 Coagulation Factors Market Trends & Drivers
1.3.1 Coagulation Factors Industry Trends
1.3.2 Coagulation Factors Market Drivers & Opportunity
1.3.3 Coagulation Factors Market Challenges
1.3.4 Coagulation Factors Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Coagulation Factors Players Revenue Ranking (2023)
2.2 Global Coagulation Factors Revenue by Company (2019-2024)
2.3 Global Coagulation Factors Players Sales Volume Ranking (2023)
2.4 Global Coagulation Factors Sales Volume by Company Players (2019-2024)
2.5 Global Coagulation Factors Average Price by Company (2019-2024)
2.6 Key Manufacturers Coagulation Factors Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Coagulation Factors Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Coagulation Factors
2.9 Coagulation Factors Market Competitive Analysis
2.9.1 Coagulation Factors Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Coagulation Factors Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coagulation Factors as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Plasma-derived
3.1.2 Recombinant
3.2 Global Coagulation Factors Sales Value by Type
3.2.1 Global Coagulation Factors Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Coagulation Factors Sales Value, by Type (2019-2030)
3.2.3 Global Coagulation Factors Sales Value, by Type (%) (2019-2030)
3.3 Global Coagulation Factors Sales Volume by Type
3.3.1 Global Coagulation Factors Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Coagulation Factors Sales Volume, by Type (2019-2030)
3.3.3 Global Coagulation Factors Sales Volume, by Type (%) (2019-2030)
3.4 Global Coagulation Factors Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmacy
4.1.2 Hospital
4.2 Global Coagulation Factors Sales Value by Application
4.2.1 Global Coagulation Factors Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Coagulation Factors Sales Value, by Application (2019-2030)
4.2.3 Global Coagulation Factors Sales Value, by Application (%) (2019-2030)
4.3 Global Coagulation Factors Sales Volume by Application
4.3.1 Global Coagulation Factors Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Coagulation Factors Sales Volume, by Application (2019-2030)
4.3.3 Global Coagulation Factors Sales Volume, by Application (%) (2019-2030)
4.4 Global Coagulation Factors Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Coagulation Factors Sales Value by Region
5.1.1 Global Coagulation Factors Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Coagulation Factors Sales Value by Region (2019-2024)
5.1.3 Global Coagulation Factors Sales Value by Region (2025-2030)
5.1.4 Global Coagulation Factors Sales Value by Region (%), (2019-2030)
5.2 Global Coagulation Factors Sales Volume by Region
5.2.1 Global Coagulation Factors Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Coagulation Factors Sales Volume by Region (2019-2024)
5.2.3 Global Coagulation Factors Sales Volume by Region (2025-2030)
5.2.4 Global Coagulation Factors Sales Volume by Region (%), (2019-2030)
5.3 Global Coagulation Factors Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Coagulation Factors Sales Value, 2019-2030
5.4.2 North America Coagulation Factors Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Coagulation Factors Sales Value, 2019-2030
5.5.2 Europe Coagulation Factors Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Coagulation Factors Sales Value, 2019-2030
5.6.2 Asia Pacific Coagulation Factors Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Coagulation Factors Sales Value, 2019-2030
5.7.2 South America Coagulation Factors Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Coagulation Factors Sales Value, 2019-2030
5.8.2 Middle East & Africa Coagulation Factors Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Coagulation Factors Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Coagulation Factors Sales Value
6.2.1 Key Countries/Regions Coagulation Factors Sales Value, 2019-2030
6.2.2 Key Countries/Regions Coagulation Factors Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Coagulation Factors Sales Value, 2019-2030
6.3.2 United States Coagulation Factors Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Coagulation Factors Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Coagulation Factors Sales Value, 2019-2030
6.4.2 Europe Coagulation Factors Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Coagulation Factors Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Coagulation Factors Sales Value, 2019-2030
6.5.2 China Coagulation Factors Sales Value by Type (%), 2023 VS 2030
6.5.3 China Coagulation Factors Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Coagulation Factors Sales Value, 2019-2030
6.6.2 Japan Coagulation Factors Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Coagulation Factors Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Coagulation Factors Sales Value, 2019-2030
6.7.2 South Korea Coagulation Factors Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Coagulation Factors Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Coagulation Factors Sales Value, 2019-2030
6.8.2 Southeast Asia Coagulation Factors Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Coagulation Factors Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Coagulation Factors Sales Value, 2019-2030
6.9.2 India Coagulation Factors Sales Value by Type (%), 2023 VS 2030
6.9.3 India Coagulation Factors Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Takeda
7.1.1 Takeda Company Information
7.1.2 Takeda Introduction and Business Overview
7.1.3 Takeda Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Takeda Coagulation Factors Product Offerings
7.1.5 Takeda Recent Development
7.2 Bayer
7.2.1 Bayer Company Information
7.2.2 Bayer Introduction and Business Overview
7.2.3 Bayer Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Bayer Coagulation Factors Product Offerings
7.2.5 Bayer Recent Development
7.3 CSL
7.3.1 CSL Company Information
7.3.2 CSL Introduction and Business Overview
7.3.3 CSL Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
7.3.4 CSL Coagulation Factors Product Offerings
7.3.5 CSL Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Information
7.4.2 Pfizer Introduction and Business Overview
7.4.3 Pfizer Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Pfizer Coagulation Factors Product Offerings
7.4.5 Pfizer Recent Development
7.5 Grifols
7.5.1 Grifols Company Information
7.5.2 Grifols Introduction and Business Overview
7.5.3 Grifols Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Grifols Coagulation Factors Product Offerings
7.5.5 Grifols Recent Development
7.6 Biogen
7.6.1 Biogen Company Information
7.6.2 Biogen Introduction and Business Overview
7.6.3 Biogen Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Biogen Coagulation Factors Product Offerings
7.6.5 Biogen Recent Development
7.7 Octapharma
7.7.1 Octapharma Company Information
7.7.2 Octapharma Introduction and Business Overview
7.7.3 Octapharma Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Octapharma Coagulation Factors Product Offerings
7.7.5 Octapharma Recent Development
7.8 NovoNordisk
7.8.1 NovoNordisk Company Information
7.8.2 NovoNordisk Introduction and Business Overview
7.8.3 NovoNordisk Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
7.8.4 NovoNordisk Coagulation Factors Product Offerings
7.8.5 NovoNordisk Recent Development
7.9 Greencross
7.9.1 Greencross Company Information
7.9.2 Greencross Introduction and Business Overview
7.9.3 Greencross Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Greencross Coagulation Factors Product Offerings
7.9.5 Greencross Recent Development
7.10 Kedrion
7.10.1 Kedrion Company Information
7.10.2 Kedrion Introduction and Business Overview
7.10.3 Kedrion Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Kedrion Coagulation Factors Product Offerings
7.10.5 Kedrion Recent Development
7.11 BPL
7.11.1 BPL Company Information
7.11.2 BPL Introduction and Business Overview
7.11.3 BPL Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
7.11.4 BPL Coagulation Factors Product Offerings
7.11.5 BPL Recent Development
7.12 Hualan Bio
7.12.1 Hualan Bio Company Information
7.12.2 Hualan Bio Introduction and Business Overview
7.12.3 Hualan Bio Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Hualan Bio Coagulation Factors Product Offerings
7.12.5 Hualan Bio Recent Development
7.13 RAAS
7.13.1 RAAS Company Information
7.13.2 RAAS Introduction and Business Overview
7.13.3 RAAS Coagulation Factors Sales, Revenue and Gross Margin (2019-2024)
7.13.4 RAAS Coagulation Factors Product Offerings
7.13.5 RAAS Recent Development
8 Industry Chain Analysis
8.1 Coagulation Factors Industrial Chain
8.2 Coagulation Factors Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Coagulation Factors Sales Model
8.5.2 Sales Channel
8.5.3 Coagulation Factors Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Coagulation Factors Market Trends
    Table 2. Coagulation Factors Market Drivers & Opportunity
    Table 3. Coagulation Factors Market Challenges
    Table 4. Coagulation Factors Market Restraints
    Table 5. Global Coagulation Factors Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Coagulation Factors Revenue Market Share by Company (2019-2024)
    Table 7. Global Coagulation Factors Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Coagulation Factors Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Coagulation Factors Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Coagulation Factors Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Coagulation Factors Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Coagulation Factors
    Table 13. Global Coagulation Factors Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coagulation Factors as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Coagulation Factors Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Coagulation Factors Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Coagulation Factors Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Coagulation Factors Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Coagulation Factors Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Coagulation Factors Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Coagulation Factors Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Coagulation Factors Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Coagulation Factors Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Coagulation Factors Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Coagulation Factors Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Coagulation Factors Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Coagulation Factors Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Coagulation Factors Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Coagulation Factors Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Coagulation Factors Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Coagulation Factors Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Coagulation Factors Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Coagulation Factors Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Coagulation Factors Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Coagulation Factors Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Coagulation Factors Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Coagulation Factors Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Coagulation Factors Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Coagulation Factors Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Coagulation Factors Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Coagulation Factors Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Coagulation Factors Sales Value by Region (2019-2024) & (%)
    Table 44. Global Coagulation Factors Sales Value by Region (2025-2030) & (%)
    Table 45. Global Coagulation Factors Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Coagulation Factors Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Coagulation Factors Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Coagulation Factors Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Coagulation Factors Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Coagulation Factors Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Coagulation Factors Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Coagulation Factors Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Coagulation Factors Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Coagulation Factors Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Coagulation Factors Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Coagulation Factors Sales Volume, (2025-2030) & (K Units)
    Table 57. Takeda Company Information
    Table 58. Takeda Introduction and Business Overview
    Table 59. Takeda Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Takeda Coagulation Factors Product Offerings
    Table 61. Takeda Recent Development
    Table 62. Bayer Company Information
    Table 63. Bayer Introduction and Business Overview
    Table 64. Bayer Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Bayer Coagulation Factors Product Offerings
    Table 66. Bayer Recent Development
    Table 67. CSL Company Information
    Table 68. CSL Introduction and Business Overview
    Table 69. CSL Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. CSL Coagulation Factors Product Offerings
    Table 71. CSL Recent Development
    Table 72. Pfizer Company Information
    Table 73. Pfizer Introduction and Business Overview
    Table 74. Pfizer Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Pfizer Coagulation Factors Product Offerings
    Table 76. Pfizer Recent Development
    Table 77. Grifols Company Information
    Table 78. Grifols Introduction and Business Overview
    Table 79. Grifols Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Grifols Coagulation Factors Product Offerings
    Table 81. Grifols Recent Development
    Table 82. Biogen Company Information
    Table 83. Biogen Introduction and Business Overview
    Table 84. Biogen Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Biogen Coagulation Factors Product Offerings
    Table 86. Biogen Recent Development
    Table 87. Octapharma Company Information
    Table 88. Octapharma Introduction and Business Overview
    Table 89. Octapharma Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Octapharma Coagulation Factors Product Offerings
    Table 91. Octapharma Recent Development
    Table 92. NovoNordisk Company Information
    Table 93. NovoNordisk Introduction and Business Overview
    Table 94. NovoNordisk Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. NovoNordisk Coagulation Factors Product Offerings
    Table 96. NovoNordisk Recent Development
    Table 97. Greencross Company Information
    Table 98. Greencross Introduction and Business Overview
    Table 99. Greencross Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Greencross Coagulation Factors Product Offerings
    Table 101. Greencross Recent Development
    Table 102. Kedrion Company Information
    Table 103. Kedrion Introduction and Business Overview
    Table 104. Kedrion Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. Kedrion Coagulation Factors Product Offerings
    Table 106. Kedrion Recent Development
    Table 107. BPL Company Information
    Table 108. BPL Introduction and Business Overview
    Table 109. BPL Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. BPL Coagulation Factors Product Offerings
    Table 111. BPL Recent Development
    Table 112. Hualan Bio Company Information
    Table 113. Hualan Bio Introduction and Business Overview
    Table 114. Hualan Bio Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Hualan Bio Coagulation Factors Product Offerings
    Table 116. Hualan Bio Recent Development
    Table 117. RAAS Company Information
    Table 118. RAAS Introduction and Business Overview
    Table 119. RAAS Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. RAAS Coagulation Factors Product Offerings
    Table 121. RAAS Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Coagulation Factors Downstream Customers
    Table 125. Coagulation Factors Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Coagulation Factors Product Picture
    Figure 2. Global Coagulation Factors Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Coagulation Factors Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Coagulation Factors Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Coagulation Factors Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Coagulation Factors Report Years Considered
    Figure 7. Global Coagulation Factors Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Coagulation Factors Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Coagulation Factors Revenue in 2023
    Figure 10. Coagulation Factors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Plasma-derived Picture
    Figure 12. Recombinant Picture
    Figure 13. Global Coagulation Factors Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Coagulation Factors Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Coagulation Factors Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Coagulation Factors Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Coagulation Factors Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Pharmacy
    Figure 19. Product Picture of Hospital
    Figure 20. Global Coagulation Factors Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Coagulation Factors Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Coagulation Factors Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Coagulation Factors Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Coagulation Factors Price by Application (2019-2030) & (USD/Unit)
    Figure 25. North America Coagulation Factors Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Coagulation Factors Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Coagulation Factors Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Coagulation Factors Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Coagulation Factors Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Coagulation Factors Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Coagulation Factors Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Coagulation Factors Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Coagulation Factors Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Coagulation Factors Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Coagulation Factors Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Coagulation Factors Sales Volume (%), (2019-2030)
    Figure 37. United States Coagulation Factors Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Coagulation Factors Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Coagulation Factors Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Coagulation Factors Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Coagulation Factors Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Coagulation Factors Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Coagulation Factors Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Coagulation Factors Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Coagulation Factors Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Coagulation Factors Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Coagulation Factors Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Coagulation Factors Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Coagulation Factors Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Coagulation Factors Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Coagulation Factors Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Coagulation Factors Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Coagulation Factors Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Coagulation Factors Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Coagulation Factors Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Coagulation Factors Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Coagulation Factors Sales Value by Application (%), 2023 VS 2030
    Figure 58. Coagulation Factors Industrial Chain
    Figure 59. Coagulation Factors Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart